Abstract
The present study investigates a synergistic adsorption/photodegradation technique catalyzed by a pectin/chitosan/zinc oxide (Pec/CS/ZnO) nanocomposite for the removal of carbamazepine (CBZ) in aqueous solutions under direct sunlight. The Pec/CS/ZnO nanocomposite was prepared by an inotropic gelation method and was characterized using different techniques. The adsorption/photocatalytic activity of the Pec/CS/ZnO nanocomposite for the remediation of CBZ was optimized using Box–Behnken design under response surface methodology. The examined parameters included the amount of Pec/CS/ZnO nanocomposite (0.25–0.75 g L−1), pH (4–10), and run time for adsorption/photo-irradiation (1–5 hours). The efficiency of CBZ degradation was calculated in terms of changes in CBZ concentration using a validated chromatographic assay. The optimum conditions for the remediation of CBZ were 0.5 g L−1 Pec/CS/ZnO nanocomposite, pH 4, and 3 hour run time. Under such conditions, the degradation efficiency of 10 mg L−1 CBZ was found to be 69.5% with a rate constant (k) of 0.00737 min−1 and half-life time of 94 min. The efficiency of the Pec/CS/ZnO nanocomposite for CBZ remediation was found to be stable and consistent after three cycles of reuse. The presence of other pharmaceutical contaminants such as acetaminophen in wastewater samples was also investigated. The efficiency of CBZ degradation was not significantly affected by the addition of acetaminophen in a 0–15 mg L−1 concentration range which confirmed the selectivity and efficiency of the proposed method for CBZ degradation and removal.
Highlights
Pharmaceuticals have long saved the lives of millions and lengthened their life spans
The performance of Pec/CS/zinc oxide (ZnO) nanocomposite has been evaluated for a synergistic adsorption/photocatalytic degradation of CBZ
The characterization study showed that Pec/CS/ ZnO nanocomposite was an excellent choice for CBZ remediation due to its porous surface, different functionalities and high surface area
Summary
Pharmaceuticals have long saved the lives of millions and lengthened their life spans. Pharmaceuticals have been able to cure deadly diseases, prevent the occurrence of certain illnesses and improve quality of life.[1] despite their success and importance, pharmaceuticals have emerged as rapidly growing environmental contaminants.[2] Recently, residues of pharmaceutical contaminants have been found in most environmental matrices and they are considered as “compounds of emerging concern”.1. Pharmaceutical residues have very great potential to harm ecosystems and threaten human health.[2] different analytical techniques, such as UPLC/MS, LC-MS/MS, and GC-MS/MS have been developed to monitor the concentration of these residues in different environmental matrices.[1] In addition, wastewater treatment plants (WWTPs) were designed to assist in their remediation process but their efficiency was less than 10% for certain pharmaceuticals.[3]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
